FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4025911000001106: Mesalazine 1g/application foam enema 14 actuation (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
68421000001119 Mesalazine 1g/application foam enema 14 actuation en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
68441000001112 Mesalazine 1g/application foam enema 14 actuation (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mesalazine 1g/application foam enema 14 actuation Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mesalazine 1g/application foam enema 14 actuation Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Mesalazine 1g/application foam enema 14 actuation Is pack of Mesalazine 1g/dose rectal foam false Inferred relationship Existential restriction modifier
Mesalazine 1g/application foam enema 14 actuation Has active ingredient Mesalazine false Inferred relationship Existential restriction modifier
Mesalazine 1g/application foam enema 14 actuation VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mesalazine 1g/application foam enema 14 actuation VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mesalazine 1g/application foam enema 14 actuation Has manufactured dose form Foam false Inferred relationship Existential restriction modifier
Mesalazine 1g/application foam enema 14 actuation Has VMP Mesalazine 1g/dose rectal foam false Inferred relationship Existential restriction modifier
Mesalazine 1g/application foam enema 14 actuation Has specific active ingredient Mesalazine true Inferred relationship Existential restriction modifier
Mesalazine 1g/application foam enema 14 actuation Has dispensed dose form Foam true Inferred relationship Existential restriction modifier
Mesalazine 1g/application foam enema 14 actuation Has VMP Mesalazine 1g/application foam enema false Inferred relationship Existential restriction modifier
Mesalazine 1g/application foam enema 14 actuation Has VMP Mesalazine 1g/application foam enema true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Asacol 1g/application foam enema (Allergan Ltd) 14 actuation Is a True Mesalazine 1g/application foam enema 14 actuation Inferred relationship Existential restriction modifier
Salofalk 1g/application foam enema (Dr. Falk Pharma UK Ltd) 14 actuation Is a True Mesalazine 1g/application foam enema 14 actuation Inferred relationship Existential restriction modifier
Mesalazine 1g/application foam enema (Ennogen Healthcare Ltd) 14 actuation Is a False Mesalazine 1g/application foam enema 14 actuation Inferred relationship Existential restriction modifier
Mesalazine 1g/application foam enema (J M McGill Ltd) 14 actuation Is a False Mesalazine 1g/application foam enema 14 actuation Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start